Faramand, Rawan
111  Ergebnisse:
?
 
?
3

Hypomethylating Agents and Venetoclax for Acute Myeloid Leu..:

Ionescu, Filip ; David, Jerel C. ; Ravichandran, Apoorva...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  6 - p. 400-406 , 2024
 
?
4

Phase II Trial of Reduced-Intensity Fludarabine, Melphalan ..:

Elmariah, Hany ; Kim, Jongphil ; DiMaggio, Elizabeth...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S58-S59 , 2024
 
?
5

The Impact of Social Determinants of Health on Brexucabtage..:

O'Connor, Timothy E ; Lin, Chenyu ; Roloff, Gregory...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S326 , 2024
 
?
7

Sirolimus Is an Acceptable Alternative to Tacrolimus for Gr..:

Elmariah, Hany ; Otoukesh, Salman ; Kumar, Ambuj...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. 229.e1-229.e11 , 2024
 
?
 
?
9

Mismatched donor allogeneic hematopoietic cell transplantat..:

Caprice, Teresa ; Fan, Wenyi ; Kim, Jongphil...
American Journal of Hematology.  99 (2024)  6 - p. 1196-1200 , 2024
 
?
10

Outcomes of Haploidentical Stem Cell Transplant Recipients ..:

Yepes, Amanda ; Faramand, Rawan G ; Bejanyan, Nelli...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S439 , 2024
 
?
12

Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 ..:

Ghobadi, Armin ; Aldoss, Ibrahim ; Maude, Shannon L....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S14-S15 , 2024
 
?
13

Expanded Antigen-Specific Donor Regulatory T Cells for Gvhd..:

Pidala, Joseph A. ; Betts, Brian C. ; Schell, Michael...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S27-S28 , 2024
 
1-15